Page 16 - IMR ANNUAL REPORT 2021: INSTITUTE FOR MEDICAL RESEARCH

IMR ANNUAL REPORT 2021 3

c
h
ar
AIRC Research
Rese
Principal
investigator /
No. Research Title NMRR Number
Co-principal
investigator

Study on the Immune Response After RESEARCH CENTRE (AIRC) ALLERGY AND IMMUNOLOGY
First Dose of Pfizer-BioNtech and Sinovac
1 Vaccines Among Recovered COVID-19 NMRR-21-290-58771 Dr Shuwahida Shuib
Patients and Non-Infected COVID-19
Subjects

Identification of Drug-Specific Genetic
Basis and Evaluation of Clinical
Effectiveness in Biologic DMARDs
2 NMRR-21-73-58111 Dr Too Chun Lai
and Targeted Synthetic DMARDs for
Treatment Stratification of Rheumatoid
Arthritis

Generation of an RNA-Based Vaccine for Dr Masita Arip /
3 NMRR-20-764-54569
COVID-19 Ching Yee Ming
Identification of Genetic Landscape
4 of Primary Immunodeficiency (PID) in NMRR-20-2387-56356 Dr Adiratna Mat
Ripen
Malaysia
Exploration of Single Cell Transcriptomics
5 in Regulatory T Cells Among Renal NMRR-20-2407-56371 Jamiila Ismail
Transplant Recipients
Association of HLA-Related
Pharmacogenomics Markers and
Dapsone-Induced Severe Cutaneous Dr Nurul Aain
6 NMRR-20-2593-57036
Adverse Reactions (SCARs)/Liver Injury Ahmad Fauzi
(DILI) in a Multi-Ethnic Malaysian
Population
MRGPRX2 Variation and Expression
of Neuromuscular Blocking Agents
7 (NMBA)-Induced Perioperative Pseudo- NMRR-20-2490-57178 Dr Mohammed
Faizal Bakhtiar
Allergic Anaphylaxis for Risk Profiling: A
Pilot Study

Prediction of Severe Dengue Using
8 Immunodiagnostic Markers and Non- NMRR-18-263-40377 Dr Norhazlin
Mustafa
HLA Gene Variants
Disease Progression of Rheumatoid
Arthritis: 10-Year Follow-Up Study Using
9 NMRR-18-1004-41421 Dr Too Chun Lai
Proteomic and Pharmacogenomics
Markers

Exploration of the Association of Genetic
10 Variations and Outcomes of Renal NMRR-17-892-35929 Koay Bee Tee
Transplant Patients
Longitudinal Study of Neutralising Dr Rafiza
11 Antibody Response Among COVID-19 NMRR-20-1676-55108 Shaharudin / Dr
Patients in Malaysia Masita Arip